In 1997, the U.S. Centers for Disease Control and Prevention (CDC) convened a group that became the National…
In 1997, planning began for Oregon Health & Science University’s (OHSU) Center for Women’s Health, and an interim…
In 1997, anesthesiologist Joanne Conroy, M.D. became the first woman appointed as head of the University of South…
On Jul. 1, 1996, topotecan (Hycamptin), the first of a class of drugs that interferes with the enzyme…
In 1996, the National Cervical Cancer Coalition (NCCC), a growing coalition of people battling cervical cancer and HPV…
In 1996, the U.S. Centers for Disease Control and Prevention (CDC) found evidence of tobacco smoke exposure in…
Dec. 27, 1995, the U.S. Food and Drug Administration (FDA) approved anastrozole (Arimidex) as a treatment for breast…
In 1995, Edward B. Lewis, Caltech graduate (Ph.D. 1942) and former faculty member, was awarded the Nobel Prize…
In 1995, Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington’s (UW) School…
In 1995, the BRCA2 gene was mapped to chromosomal 13q. Just fifteen months later, Wooster et al. reported…
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
On Oct. 7, 1994, a strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and…
In 1994, the National Violence against Women Survey was created by the U.S. Centers for Disease Control and…
In 1994, Albert Einstein College of Medicine becomes the only New York City medical school selected by the…
On Jul. 22, 1993, revising a policy from 1977 that excluded women of childbearing potential from early drug…
On Jun. 10, 1993, the U.S. Congress signed the National Institutes of Health Revitalization Act, P.L. 103-43. The…
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched. The trial was designed to determine whether…
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress…
In 1992, the National Cancer Institute (NCI) awarded the Pacific Health Research Institute its largest and most enduring…
In 1991, the U.S. Centers for Disease Control and Prevention (CDC) began developing a national strategic plan for…
In 1991, the Women’s Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was…
In 1990, Geneticist Mary-Claire King and her colleagues at the University of California, Berkeley (UC Berkeley) discovered BRCA1,…
On Mar. 3, 1989, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers’ PARAPLATIN (carboplatin) for the treatment…
In 1989, Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells….
In 1989, the State Office of Rural Health became part of Oregon Health & Science University (OHSU) to…
In December 1988, the National Cancer Institute (NCI) sponsored a workshop to address the standardization of cervical/vaginal cytopathology…
On Jul. 20, 1988, the U.S. Food and Drug Administration (FDA) announced that the Modernization Act of 1997…